Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -135,789 | -91,373 | -62,147 | -28,273 | -111,985 |
| Depreciation Amortization | 6,122 | 4,380 | 2,610 | 1,042 | 1,277 |
| Accounts receivable | 1,114 | 168 | -1,696 | -4,319 | 1,183 |
| Other Working Capital | -22,136 | -33,506 | -25,248 | -8,633 | 12,269 |
| Other Operating Activity | 22,150 | 17,241 | 18,712 | 11,918 | 32,561 |
| Operating Cash Flow | $-128,539 | $-103,090 | $-67,769 | $-28,265 | $-64,695 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -139,455 | -185,590 | -177,947 | -176,669 | N/A |
| PPE Investments | -25,444 | -22,305 | -9,841 | -5,326 | -2,370 |
| Purchase Of Investment | N/A | 0 | N/A | N/A | -7,897 |
| Sale Of Investment | 7,250 | 3,250 | 3,250 | N/A | N/A |
| Purchase Sale Intangibles | -1,381 | -1,062 | -628 | -294 | -1,405 |
| Other Investing Activity | -1,381 | -1,062 | -628 | -294 | -1,405 |
| Investing Cash Flow | $-159,030 | $-205,707 | $-185,166 | $-182,289 | $-11,672 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -94 | -70 | -47 | -23 | -89 |
| Common Stock Issued | 104,249 | 104,201 | 98,771 | 2,713 | 145,986 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -226 |
| Financing Cash Flow | $104,155 | $104,131 | $98,724 | $2,690 | $145,671 |
| Beginning Cash Position | 256,965 | 256,965 | 256,965 | 256,965 | 187,661 |
| End Cash Position | 73,551 | 52,299 | 102,754 | 49,101 | 256,965 |
| Net Cash Flow | $-183,414 | $-204,666 | $-154,211 | $-207,864 | $69,304 |
| Free Cash Flow | |||||
| Operating Cash Flow | -128,539 | -103,090 | -67,769 | -28,265 | -64,695 |
| Capital Expenditure | -25,444 | -22,305 | -9,841 | -5,326 | -2,370 |
| Free Cash Flow | -153,983 | -125,395 | -77,610 | -33,591 | -67,065 |